mRNA vaccine - Wikipedia
mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery
How mRNA vaccines work without an added adjuvant
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Michael Hogan, PhD
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice - ScienceDirect
Michael Hogan - Senior Advisor - The Regulatory Assistance Project | LinkedIn
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
Michael Hogan - Co-Founder & Chief Scientific Officer @ PathogenDx - Crunchbase Person Profile
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement | ACS Nano
Moderna Drops After Losing Appeal Over Drug-Delivery Patents (2)
The 'anti-hype' vaccine | Nature Biotechnology
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability | npj Vaccines
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery | Nature Protocols
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
Michael Hogan - Postdoctoral Research Fellow - Children's Hospital of Philadelphia | LinkedIn
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
Machine Learning for Designing Next-Generation mRNA Therapeutics | Accounts of Chemical Research
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Vaccines | Free Full-Text | An Update on Self-Amplifying mRNA Vaccine Development
